Feb 25, 2026 08:00AM

Feb 19, 2026 08:01AM

Feb 19, 2026 08:00AM

Jan 29, 2026 08:05AM

Jan 29, 2026 08:00AM

Jan 28, 2026 05:00PM

Jan 28, 2026 05:00PM Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jan 28, 2026 08:01AM

Jan 28, 2026 08:00AM

Dec 29, 2025 08:00AM

Dec 29, 2025 08:00AM

Dec 15, 2025 09:00AM

Dec 12, 2025 04:46PM

Dec 12, 2025 04:46PM Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

Dec 11, 2025 01:43PM

Dec 11, 2025 01:43PM

Dec 9, 2025 08:00AM

Dec 9, 2025 08:00AM

Dec 4, 2025 08:00AM

Nov 26, 2025 08:00AM

Nov 26, 2025 08:00AM Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

Nov 14, 2025 04:05PM

Oct 23, 2025 08:00AM

Oct 23, 2025 08:00AM

Oct 16, 2025 08:32AM

Oct 16, 2025 08:30AM

Oct 15, 2025 08:01AM

Oct 15, 2025 08:00AM Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

Oct 14, 2025 09:02AM

Oct 14, 2025 09:00AM

Oct 2, 2025 08:45AM

Oct 2, 2025 08:45AM

Sep 18, 2025 04:30PM

Sep 18, 2025 04:30PM

Sep 17, 2025 09:24AM Enveric Biosciences raises $2.2 million through warrant exercise

Sep 17, 2025 09:24AM

Sep 17, 2025 08:00AM

Sep 16, 2025 08:45AM

Sep 16, 2025 08:45AM

Sep 3, 2025 08:30AM

Sep 2, 2025 08:30AM

Aug 28, 2025 08:30AM Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

Aug 14, 2025 08:00AM

Jul 23, 2025 08:03AM

Jul 23, 2025 08:03AM

Jul 15, 2025 09:04AM

Jul 15, 2025 09:03AM

Jun 24, 2025 09:03AM

Jun 24, 2025 09:03AM Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

Jun 16, 2025 10:46AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All